4 results match your criteria: "Medical School University of Rijeka and Osijek[Affiliation]"
J Cardiothorac Vasc Anesth
October 2015
School of Medicine, University of Zagreb, University Hospital Center Zagreb, Cardiac Surgery Department, Zagreb, Croatia.
Clin Cardiol
July 2015
Department of Cardiology, University Hospital "Thalassotherapia Opatija", Medical School University of Rijeka and Osijek, Opatija, Croatia.
J Cardiothorac Vasc Anesth
December 2014
Department of Cardiovascular Diseases, School of Medicine University of Zagreb, University Hospital Center Zagreb Zagreb, Croatia.
Thorac Cardiovasc Surg
February 2015
Department of Cardiac Surgery, University of Zagreb School of Medicine-University Hospital Center Zagreb, Zagreb, Croatia.
Excessive bleeding after cardiopulmonary bypass (CPB) operations remains to be a persistent problem and weak platelet function certainly contributes to bleeding diathesis. Antiplatelet therapy (APT) is an integral component of perioperative management in patients undergoing cardiac surgery procedures, both with and without use of CPB. In addition to individual variability in platelet function, different preoperative APT administration/discontinuation management further affects platelet function, which in turn may reflect bleeding tendency.
View Article and Find Full Text PDF